Filter posts

Benefiting from Innovative Clinical Trial Designs

Clinical trial success rates have been known to be low for some time now, but …

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of …

Lawsuit Against UnitedHealth Put Insurers’ Practices Under Scrutiny

Reuters reports that UnitedHealth Group, the nation’s largest insurer, has been sued by three patients …

Cancer Docs Weigh in on Medicare Part B Demo

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford …

Be Prepared This Flu Season and Get Vaccinated

It can only mean one thing when long summer days have come to an end, …

NORD President: Congress must act now to help 15 million sick children

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall …

BIO Launches New Website Holding Insurers Accountable: Un-surance.com

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure …

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which …

ICYMI: Making Biopharmaceutical Innovation a Priority of the Next Administration

Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, “How The …

ICYMI: Peter Pitts Weighs in on Drug Price Debate

This week in the Sacramento Bee, Peter J. Pitts, a former U.S. Food and Drug …